After four highly successful editions across India and Dubai, Eminence Group proudly announces the return of its flagship event, the 5th Edition Drug Safety Symposium 2026 – Middle East Chapter, to be held on January 21st & 22nd, 2026 at the Grand Mercure Dubai Airport Hotel, Dubai.

在印度和迪拜成功举办了四届之后，Eminence集团自豪地宣布其旗舰活动——2026年第五届药物安全研讨会中东分会的回归，该会议将于2026年1月21日和22日在迪拜格兰德美居迪拜机场酒店举行。

Recognized as one of the most influential pharmacovigilance (PV) gatherings in the region, the symposium continues its mission to advance patient safety and regulatory excellence across the Middle East. The 2026 edition, themed “Pharmacovigilance 360°: Building Patient Safety from Clinical Trials to Post-Market,” will deliver a comprehensive exploration of drug safety across the entire product lifecycle, from clinical research to real-world application..

作为该地区最具影响力的药物警戒（PV）会议之一，本次研讨会继续其使命，推动中东地区的患者安全和监管卓越。2026年会议以“药物警戒360°：从临床试验到上市后全方位构建患者安全”为主题，将全面探讨药品在整个产品生命周期中的安全性，从临床研究到实际应用。

Expanding the Scope: From Compliance to Culture

扩大范围：从合规到文化

This year, the symposium goes beyond traditional post-marketing surveillance to cover clinical trial safety, pre-approval submissions, lifecycle risk management, and digital transformation in PV. It aims to build a culture of proactive, patient-centric safety, moving from checklist-based compliance to strategic, continuous readiness..

今年，该研讨会超越了传统的上市后监测，涵盖了临床试验安全性、批准前提交、生命周期风险管理以及药物警戒中的数字化转型。其目标是建立一种积极主动、以患者为中心的安全文化，从基于清单的合规性转向战略性、持续性的准备状态。

Unlike conventional conferences, the Drug Safety Symposium is built around interactive, practice-driven engagement. Delegates can expect live challenge sessions, mock inspections, hands-on workshops, and real-world case studies that translate regulatory theory into practical implementation.

与传统会议不同，药物安全研讨会围绕互动、实践驱动的参与展开。参会者可以期待现场挑战环节、模拟检查、动手实践的工作坊以及将监管理论转化为实际应用的真实案例研究。

Key Sessions and Highlights

重点会议和亮点

The two-day event features a rich mix of keynotes, panel discussions, and immersive workshops, including:

为期两天的活动包括主题演讲、小组讨论和沉浸式研讨会等丰富内容，具体如下：

Global Participation and Regional Impact

全球参与和地区影响

The symposium will feature speakers and participants from more than 10 countries, including leaders from Novartis, Pfizer, AstraZeneca, Hikma, Julphar, and Tabuk, alongside senior representatives from national regulatory authorities.

本次研讨会将邀请来自十多个国家的演讲者和与会者，包括诺华、辉瑞、阿斯利康、Hikma、Julphar 和 Tabuk 的领导人，以及国家监管机构的高级代表。

“Our goal is to make pharmacovigilance practical, proactive, and truly patient-focused,” said Ms. Guneet Hayer, Managing Director, Eminence Group. “The 5th Edition Drug Safety Symposium 2026 – Middle East Chapter isn’t just another conference; it’s a working forum where regulators, industry, and academia collaborate to build stronger, smarter, and more resilient safety systems for the region.”.

“我们的目标是使药物警戒工作变得切实可行、积极主动，并真正以患者为中心，”埃米内斯集团董事总经理古尼特·海耶尔女士表示。“2026年第五届药物安全研讨会——中东分会不仅仅是一场会议；它是一个工作论坛，监管机构、行业和学术界在此携手合作，为该地区构建更强大、更智能、更具韧性的安全体系。”

By fostering open dialogue between regulators, industry experts, and technology innovators, the 5th Edition Drug Safety Symposium 2026 – Middle East Chapter aims to create tangible outcomes, including frameworks for ADR reporting, stronger industry–regulator collaboration, and practical models for risk and crisis management..

通过促进监管机构、行业专家和技术革新者之间的开放对话，2026年第五届药物安全研讨会——中东分会旨在取得实质性成果，包括制定不良反应报告框架、加强行业与监管机构的合作，以及建立风险和危机管理的实用模型。

About Eminence Group Ventures

关于卓越集团风险投资

Eminence Group Ventures is a leading organizer of high-impact pharma and life sciences conferences across India and the Middle East, known for connecting global expertise with regional insight.

卓越集团创投是印度和中东地区高影响力制药和生命科学会议的领先组织者，以将全球专业知识与区域洞察力相结合而闻名。

Event Details:

事件详情：

DATE

日期

: January 21st – 22nd, 2026

：2026年1月21日 - 22日

VENUE

场地

: Grand Mercure Dubai Airport Hotel, UAE

迪拜机场美居酒店，阿联酋

For speaker opportunities, partnerships, and delegate registration, contact:

有关演讲机会、合作和代表注册，请联系：

Suryansh@eminencemedia.in | www.drugsafetysymposium.com

苏里亚什@卓越媒体.in | www.药物安全研讨会.com